PubRank

C R Rinaldo

Author PubWeight™ 213.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996 18.38
2 The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987 17.36
3 Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997 16.44
4 Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999 10.41
5 Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995 6.90
6 KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996 5.96
7 Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet 1987 4.33
8 Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996 4.13
9 Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 2000 3.73
10 The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992 3.32
11 High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997 2.78
12 Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med 1979 2.49
13 New bacterial agent of pneumonia isolated from renal-transplant recipients. Lancet 1979 2.45
14 Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med 1989 2.44
15 Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 1980 2.41
16 Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis 1977 2.30
17 Variables influencing condom use in a cohort of gay and bisexual men. Am J Public Health 1988 2.26
18 Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med 1988 2.18
19 Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr 2000 2.13
20 Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol 1999 2.11
21 Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA 1990 2.00
22 AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS 1989 1.80
23 Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. AIDS 1998 1.74
24 Replication of herpes simplex virus and cytomegalovirus in human leukocytes. J Immunol 1978 1.69
25 Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A 1996 1.68
26 No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr 1990 1.67
27 Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 1993 1.67
28 The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep 1987 1.62
29 Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology 1998 1.57
30 Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol 1991 1.57
31 Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987 1.49
32 Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1994 1.47
33 Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis 1979 1.46
34 Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 2001 1.45
35 Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay. Clin Infect Dis 1999 1.44
36 Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996 1.42
37 Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1990 1.39
38 Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol 1987 1.37
39 Marketing strategies for recruiting gay men into AIDS research and education projects. J Community Health 1986 1.35
40 CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. J Immunol 1994 1.32
41 Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000 1.32
42 The effect of group education on improving attitudes about AIDS risk reduction. N Y State J Med 1987 1.32
43 Human polymorphonuclear leukocyte interaction with cyclosporine A. Infect Immun 1984 1.27
44 HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol 1986 1.23
45 Changes in HIV rates and sexual behavior among homosexual men, 1984 to 1988/92. Am J Public Health 1993 1.22
46 Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995 1.22
47 Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1995 1.18
48 Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression. Am J Epidemiol 2002 1.11
49 Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1999 1.07
50 Mycoplasma-associated induction of interferon in ovine leukocytes. Infect Immun 1973 1.05
51 The ultrastructural morphologic features of Pittsburgh pneumonia agent. Am J Pathol 1980 1.04
52 Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996 1.03
53 Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989 1.02
54 HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. J Immunol 1989 1.00
55 The effect of fresh lymphocytes on increased sensitivity of HIV-1 isolation: a multicenter study. J Acquir Immune Defic Syndr 1990 1.00
56 Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex. Cytometry 2000 1.00
57 Prevalence of chlamydia and gonorrhoea among a population of men who have sex with men. Sex Transm Infect 2002 0.99
58 Natural killer cell activity in renal transplant recipients receiving cyclosporine. Infect Immun 1983 0.97
59 Induction of interferon in mice by mycoplasmas. Infect Immun 1974 0.97
60 Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men. J Clin Immunol 1987 0.97
61 Viral replication and interferon production in fetal and adult ovine leukocytes and spleen cells. Infect Immun 1975 0.97
62 Natural killer cell responses in homosexual men with early HIV infection. J Acquir Immune Defic Syndr 1990 0.96
63 Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J Infect Dis 1986 0.96
64 HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines. J Immunol 1999 0.95
65 Induction of interferon in ovine leukocytes by species of mycoplasma and acholeplasma. Proc Soc Exp Biol Med 1974 0.95
66 Fetal and adult bovine interferon production during bovine viral diarrhea virus infection. Infect Immun 1976 0.94
67 Distinguishing baboon cytomegalovirus from human cytomegalovirus: importance for xenotransplantation. J Infect Dis 1997 0.94
68 Factors related to seroconversion among homo- and bisexual men after attending a risk-reduction educational session. AIDS 1989 0.94
69 Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men. J Infect Dis 1989 0.93
70 A phase I study of ampligen in human immunodeficiency virus-infected subjects. J Infect Dis 1992 0.93
71 Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis. Infect Immun 1983 0.92
72 Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells. J Virol 2001 0.92
73 Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants. Am J Epidemiol 2004 0.91
74 Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989. J Acquir Immune Defic Syndr 1991 0.91
75 CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects. Clin Diagn Lab Immunol 2000 0.91
76 Activation of latent viruses following bone marrow transplantation. Transplant Proc 1976 0.89
77 Characterization of herpes simplex virus persistence in a human T lymphoblastoid cell line. Infect Immun 1981 0.89
78 Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin Microbiol 1991 0.89
79 Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay. Clin Diagn Virol 1997 0.88
80 CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals. J Infect Dis 2000 0.87
81 A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia. J Clin Microbiol 2000 0.87
82 Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J Clin Microbiol 1989 0.86
83 Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection. Clin Exp Immunol 1988 0.86
84 Use of interferon in cytomegalovirus infections in man. Tex Rep Biol Med 1977 0.86
85 Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol 2001 0.86
86 Persistent infection of human lymphoid and myeloid cell lines with herpes simplex virus. Infect Immun 1979 0.86
87 Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Med 2009 0.85
88 Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men. J Viral Hepat 2013 0.85
89 Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy. J Med Virol 1999 0.85
90 Polymorphonuclear leukocyte function during cytomegalovirus mononucleosis. Clin Immunol Immunopathol 1979 0.84
91 CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. J Acquir Immune Defic Syndr 1993 0.84
92 HIV heterosexual transmission in hemophilia couples: lack of relation to T4 number, clinical diagnosis, or duration of HIV exposure. J Acquir Immune Defic Syndr 1989 0.84
93 Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.84
94 Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. Am J Epidemiol 1992 0.84
95 Loss of T cell receptor Vbeta repertoires in HIV type 1-infected SCID-hu mice. AIDS Res Hum Retroviruses 1997 0.83
96 Resistance of visna virus to interferon. J Infect Dis 1978 0.83
97 Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells. AIDS Res Hum Retroviruses 1990 0.83
98 Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses. AIDS Res Hum Retroviruses 1999 0.82
99 Excretion of cytomegalovirus in semen associated with HTLV-III seropositivity in asymptomatic homosexual men. J Med Virol 1986 0.82
100 Antibody-dependent cellular cytotoxicity mediated by CD16+ lymphocytes from HIV-seropositive homosexual men. Clin Immunol Immunopathol 1990 0.81
101 Random depletion of T cells that bear specific T cell receptor V beta sequences in AIDS patients. J Leukoc Biol 1993 0.81
102 Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. AIDS 1992 0.80
103 Growth of the Pittsburgh pneumonia agent in animal cell cultures. Infect Immun 1981 0.80
104 Alteration of immunoregulatory mechanisms during cytomegalovirus mononucleosis: effect of in vitro culture on lymphocyte blastogenesis to viral antigens. Clin Immunol Immunopathol 1983 0.80
105 Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes. Clin Exp Immunol 2014 0.79
106 Primary lymphadenopathic Kaposi's sarcoma in an immunocompetent 23-year-old man. Am J Clin Pathol 1986 0.79
107 Apoptosis parallels lymphopoiesis in bone marrow transplantation and HIV disease. Res Immunol 1995 0.79
108 HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs. Public Health Rep 1988 0.79
109 Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection. Adv Virol 2011 0.78
110 Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine. Clin Immunol Immunopathol 1986 0.78
111 Secondary prevention of HIV: knowledge and beliefs about HIV, therapy and community resources. AIDS 1993 0.77
112 Coevolution of virulent virus and resistant cells as a mechanism of persistence of herpes simplex virus type 1 in a human T lymphoblastoid cell line. J Gen Virol 1989 0.77
113 Preventing HIV infection in gay and bisexual men: experimental evaluation of attitude change from two risk reduction interventions. AIDS Educ Prev 1990 0.77
114 Effects of enhancing agents on detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1994 0.76
115 Stimulation of Anti-HIV-1 Cytotoxic T Lymphocytes by Dendritic Cells. Methods Mol Med 2001 0.76
116 Seroprevalence of HIV-1 and HIV-2 infection among children diagnosed with protein-calorie malnutrition in Nigeria. Epidemiol Infect 1993 0.75
117 Stimulation of IFN-alpha production in HLA-DR+, light density peripheral blood mononuclear cells by human immunodeficiency virus. J Exp Pathol 1990 0.75
118 The T-cell receptor V beta repertoire in naive and human immunodeficiency virus-1 (HIV-1) infected chimpanzees. J Med Primatol 1994 0.75
119 Chlamydia specific IgG and IgA serum antibodies in a study of homosexual men at various clinical stages of HIV related disease. In Vivo 1995 0.75
120 Projecting disease when death is likely. Am J Epidemiol 1996 0.75
121 Guidelines for disclosing HIV-antibody test results to clients. Nurse Pract 1992 0.75
122 Expression of cytokine mRNA by human peripheral blood dendritic cells stimulated with human immunodeficiency virus and herpes simplex virus. Adv Exp Med Biol 1995 0.75
123 Biological response modifier enhances the activity of natural killer cell against human cytomegalovirus-infected cells. J Med Virol 1989 0.75
124 Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor, native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay. Mod Pathol 1994 0.75
125 Replication-defective HIV as a vaccine candidate. AIDS Res Hum Retroviruses 1998 0.75
126 HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection. J Hum Virol 2002 0.75
127 Heterosexual partners of haemophiliacs must refrain from blood donation. Lancet 1986 0.75
128 A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine. AIDS 1994 0.75
129 Comparison of monoclonal antibodies for immunostaining in the cytomegalovirus shell vial assay on 4,388 specimens. J Med Virol 1995 0.75
130 T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development. J Gen Virol 1995 0.75
131 Mycoplasma in biological systems: induction of interferon. Health Lab Sci 1976 0.75
132 Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV related diseases in homosexual men. J Med Virol 1991 0.75